RLF AgTech Posts 74% Revenue Growth, Raises $4.5M at Discount

RLF AgTech Ltd has secured $4.5 million through a discounted share placement to support its strategic growth initiatives following a robust 74% revenue increase in FY2025. The company is advancing its Australian relaunch, expanding manufacturing, and entering new Asian markets.

  • Raised $4.5 million via placement at 15.3% discount
  • FY2025 revenue surged 74% to $26 million with positive operating cash flow
  • Relaunched Australian business with national distribution network
  • Expanded manufacturing capacity and strengthened China operations
  • Entered Southeast Asia and India markets; launched biological products
An image related to Rlf Agtech Ltd
Image source middle. ©

Strong Financial Turnaround

RLF AgTech Ltd (ASX – RLF) has announced a $4.5 million equity raising through a placement of approximately 90.4 million new shares priced at $0.05 each, representing a 15.3% discount to the last closing price. This capital injection follows a year of significant operational progress, with FY2025 revenues climbing 74% to $26 million and the company achieving positive net operating cash flow for the first time in several years.

The improved financial footing reflects a strategic reset initiated in mid-2024, including management restructuring, cost reductions, and a sharpened focus on sales and profitability. Notably, the company reduced legacy debt by around $2 million and strengthened its cash balance to $6.5 million as of June 2025.

Strategic Growth and Market Expansion

RLF’s growth story is anchored by its specialty liquid fertilisers and biological products, which address pressing agricultural challenges such as sustainable crop nutrition and soil health improvement. The company has relaunched its Australian operations, regaining full commercial rights and establishing a distribution network spanning over 700 retail outlets through a new partnership with Nutrien Ag Solutions.

Manufacturing capacity has been enhanced with an upgraded Queensland facility, enabling faster response times and cost efficiencies. Meanwhile, the China business rebounded strongly, with cash collections hitting a record $5.26 million and pre-orders up 73% year-on-year. Expansion efforts continue in Southeast Asia, particularly Vietnam, and the company has initiated trials in India, targeting one of the world’s largest agricultural markets.

Product Innovation and Sustainability Focus

RLF has broadened its product portfolio by securing exclusive distribution rights for AXIOMA’s plant-based biostimulants, marking its entry into the high-growth biologicals sector. The company’s products are backed by over 20 years of data and independent trials demonstrating yield increases of 10% to 30% and strong returns on investment for farmers.

Environmental sustainability is a core theme, with RLF’s offerings designed to improve fertiliser efficiency, reduce environmental impact, and support regenerative agriculture. The Hillston Soil Carbon Project further validates the company’s commitment to carbon sequestration and soil health.

Risks and Outlook

Despite the positive momentum, RLF acknowledges risks including reputational challenges, economic volatility, regulatory changes, and climate-related disruptions. The company’s ability to retain key personnel and manage competitive pressures will also be critical as it scales operations across diverse markets.

With a refreshed board and leadership team, RLF is positioning itself to capitalize on the fastest-growing segments of the agri-sector in the Asia-Pacific region. The equity raising provides the necessary capital to fund raw materials, manufacturing, human resources, and balance sheet improvements, setting the stage for sustained growth.

Bottom Line?

RLF’s capital raise and strategic initiatives mark a pivotal step in its transformation, but execution risks remain as it scales across complex markets.

Questions in the middle?

  • How quickly will RLF’s Australian distribution network translate into meaningful revenue growth?
  • What are the prospects and timelines for commercial success in India and Southeast Asia?
  • How will RLF manage competitive pressures and regulatory risks in its expanding markets?